LYNPARZA 150mg film-coated tablets ASTRAZENECA ORIGINAL MEDICINE
Chemical substance: olaparib
ATC code: L01XX46 • Antineoplastic and immunomodulating agents | Other antineoplastic agents
Active substance
Results for the substance olaparib
3 results
About this active substance
Olaparib is a medication used for the treatment of certain types of cancer, such as ovarian, breast, or prostate cancer, associated with BRCA gene mutations. It is a poly(ADP-ribose) polymerase (PARP) inhibitor that interferes with DNA repair in cancer cells, leading to their death.
The medication is taken orally, usually twice daily, as directed by your doctor. It is important to follow the treatment regimen and undergo regular check-ups to monitor effectiveness and potential side effects.
Side effects may include nausea, fatigue, anemia, diarrhea, or, in rare cases, myelodysplastic syndrome.
Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of olaparib.
The medication is taken orally, usually twice daily, as directed by your doctor. It is important to follow the treatment regimen and undergo regular check-ups to monitor effectiveness and potential side effects.
Side effects may include nausea, fatigue, anemia, diarrhea, or, in rare cases, myelodysplastic syndrome.
Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of olaparib.
-
-
LYNPARZA 100mg film-coated tablets ASTRAZENECA ORIGINAL MEDICINE
Chemical substance: olaparib
ATC code: L01XX46 • Antineoplastic and immunomodulating agents | Other antineoplastic agents
-
LYNPARZA 50mg capsules ASTRAZENECA ORIGINAL MEDICINE
Chemical substance: olaparib
ATC code: L01XX46 • Antineoplastic and immunomodulating agents | Other antineoplastic agents